Summary

रोग में Chromatin Proteomes के मात्रात्मक विश्लेषण

Published: December 28, 2012
doi:

Summary

मास स्पेक्ट्रोमेट्री अग्रिम में प्रोटीन अभिव्यक्ति और ऊतकों की एक मेजबान में संशोधन के उच्च throughput विश्लेषण की अनुमति दी है. Subcellular fractionation और रोग मॉडल, मात्रात्मक जन स्पेक्ट्रोमेट्री और जैव सूचना विज्ञान जैविक प्रणालियों में नए गुण प्रकट कर सकते हैं के साथ संयुक्त है. यहाँ वर्णित विधि हृदय रोग की सेटिंग में chromatin जुड़े प्रोटीन का विश्लेषण करता है और आसानी से दूसरे के लिए लागू है<em> Vivo में</em> मानव रोग के मॉडल.

Abstract

In the nucleus reside the proteomes whose functions are most intimately linked with gene regulation. Adult mammalian cardiomyocyte nuclei are unique due to the high percentage of binucleated cells,1 the predominantly heterochromatic state of the DNA, and the non-dividing nature of the cardiomyocyte which renders adult nuclei in a permanent state of interphase.2 Transcriptional regulation during development and disease have been well studied in this organ,3-5 but what remains relatively unexplored is the role played by the nuclear proteins responsible for DNA packaging and expression, and how these proteins control changes in transcriptional programs that occur during disease.6 In the developed world, heart disease is the number one cause of mortality for both men and women.7 Insight on how nuclear proteins cooperate to regulate the progression of this disease is critical for advancing the current treatment options.

Mass spectrometry is the ideal tool for addressing these questions as it allows for an unbiased annotation of the nuclear proteome and relative quantification for how the abundance of these proteins changes with disease. While there have been several proteomic studies for mammalian nuclear protein complexes,8-13 until recently14 there has been only one study examining the cardiac nuclear proteome, and it considered the entire nucleus, rather than exploring the proteome at the level of nuclear sub compartments.15 In large part, this shortage of work is due to the difficulty of isolating cardiac nuclei. Cardiac nuclei occur within a rigid and dense actin-myosin apparatus to which they are connected via multiple extensions from the endoplasmic reticulum, to the extent that myocyte contraction alters their overall shape.16 Additionally, cardiomyocytes are 40% mitochondria by volume17 which necessitates enrichment of the nucleus apart from the other organelles. Here we describe a protocol for cardiac nuclear enrichment and further fractionation into biologically-relevant compartments. Furthermore, we detail methods for label-free quantitative mass spectrometric dissection of these fractions-techniques amenable to in vivo experimentation in various animal models and organ systems where metabolic labeling is not feasible.

Protocol

प्रयोगात्मक कार्यप्रवाह सात प्रमुख कदम (1 चित्रा) शामिल हैं. किसी भी नमूने है कि मास स्पेक्ट्रोमीटर पर चला जाएगा जुड़े काम के लिए एक प्रयोगशाला कोट, दस्ताने और बाल शुद्ध experimenter पहनते हैं और धूल और क?…

Representative Results

चित्रा 4 रिश्तेदार मात्रा का ठहराव के लिए इस प्रपत्र की उपयोगिता पर प्रकाश डाला गया. बाएं पैनल में दिखाया गया व्यक्ति monoisotopic पेप्टाइड अलग चूहों से मढ़ा चोटियों, है जो प्रोटीन HMGB1 डेटाबेस खोज के माध्?…

Discussion

पहले परमाणु अलगाव के लिए दो मुख्य तरीकों की समीक्षा की गई है: एक 27 Behrens एक गैर जलीय विलायक में lyophilized ऊतक homogenizing की तकनीक और दूसरा, एक संशोधन जिनमें से हम यहाँ का उपयोग एक जलीय sucrose / नमक के घोल में ऊतक homogenizing की ह?…

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

प्रयोगशाला Vondriska NIH और UCLA में Laubisch बंदोबस्ती के राष्ट्रीय हृदय, फेफड़े और रक्त संस्थान से अनुदान द्वारा समर्थित है. EM जेनिफर एस UCLA में फिजियोलॉजी में Buchwald ग्रेजुएट फैलोशिप के प्राप्तकर्ता है, कोर्ट एक अमेरिकन हार्ट एसोसिएशन के पूर्व डॉक्टरेट फैलोशिप के प्राप्तकर्ता है, सांसद एक NIH रुथ Kirschstein पोस्ट डॉक्टरेट फैलोशिप के प्राप्तकर्ता है, और एस एफ के प्राप्तकर्ता है एक NIH K99 पुरस्कार से सम्मानित किया गया.

Materials

Name of the reagent Company Catalogue number
Dulbeco Modified Eagle Medium Invitrogen 11965
Protease pellet Roche 04 693 159 001
100 μm strainer BD Falcon 352360
Ultracut ultramicrotome Reichert  
100CX Transmission Electron
Microscope
JEOL USA, Inc.  
Oriole BioRad 161-0496
Histone H2A antibody Santa Cruz sc-8648
Nucleoporin p62 antibody BD Biosciences 610498
Adenine nucleotide transporter antibody Santa Cruz sc-9299
BiP antibody Santa Cruz sc-1050
Tubulin antibody Sigma T1568
Histone H3 antibody Abcam ab1791
Fibrillarin antibody Cell Signaling C12C3
SNRP70 antibody Abcam ab51266
E2F-1 antibody Thermo Fisher MS-879
Retinoblastoma antibody BD Biosciences 554136
Hypoxia inducible factor-1 antibody Novus Biologicals NB100-469
BCA protein assay Thermo Scientific 23227
Reverse phase column New Objective PFC7515-B14-10
BioWorks Browser Thermo Scientific  

Riferimenti

  1. Li, F., Wang, X., Capasso, J. M., Gerdes, A. M. Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J Mol Cell Cardiol. 28, 1737-1746 (1996).
  2. Rumyantsev, P. P. Interrelations of the proliferation and differentiation processes during cardiact myogenesis and regeneration. Int Rev. Cytol. 51, 186-273 (1977).
  3. Olson, E. N., Schneider, M. D. Sizing up the heart: development redux in disease. Genes Dev. 17, 1937-1956 (2003).
  4. Molkentin, J. D., Dorn, G. W. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev. Physiol. 63, 391-426 (2001).
  5. Fishman, M. C., Chien, K. R. Fashioning the vertebrate heart: earliest embryonic decisions. Development. 124, 2099-2117 (1997).
  6. Rajabi, M., Kassiotis, C., Razeghi, P., Taegtmeyer, H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev. 12, 331-343 (2007).
  7. Roger, V. L., et al. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 123, e18-e209 (2011).
  8. Schirmer, E. C., Florens, L., Guan, T., Yates, J. R., Gerace, L. Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science. 301, 1380-1382 (2003).
  9. Lambert, J. P., Mitchell, L., Rudner, A., Baetz, K., Figeys, D. A novel proteomics approach for the discovery of chromatin-associated protein networks. Mol. Cell Proteomics. 8, 870-882 (2009).
  10. Malik, P., et al. Cell-specific and lamin-dependent targeting of novel transmembrane proteins in the nuclear envelope. Cell Mol Life Sci. 67, 1353-1369 (2010).
  11. Tweedie-Cullen, R. Y., Reck, J. M., Mansuy, I. M. Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J. Proteome Res. 8, 4966-4982 (2009).
  12. Chu, D. S., et al. Sperm chromatin proteomics identifies evolutionarily conserved fertility factors. Nature. 443, 101-105 (2006).
  13. Uchiyama, S., et al. Proteome analysis of human metaphase chromosomes. J. Biol. Chem. 280, 16994-17004 (2005).
  14. Franklin, S., et al. Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy. Mol. Cell Proteomics. 10, (2011).
  15. Kislinger, T., et al. Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell. 125, 173-186 (2006).
  16. Moore, D. H., Ruska, H. Electron microscope study of mammalian cardiac muscle cells. J. Biophys Biochem. Cytol. 3, 261-268 (1957).
  17. Anversa, P., Vitali-Mazza, L., Visioli, O., Marchetti, G. Experimental cardiac hypertrophy: a quantitative ultrastructural study in the compensatory stage. J. Mol. Cell Cardiol. 3, 213-227 (1971).
  18. Franklin, S., et al. Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy. Mol Cell. Proteomics. 10, (2011).
  19. Paulsson, A. K., et al. Post-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophy. Journal of molecular and cellular cardiology. 48, 1206-1214 (2010).
  20. Franklin, S., et al. Quantitative analysis of the chromatin proteome in disease reveals remodeling principles and identifies high mobility group protein b2 as a regulator of hypertrophic growth. Mol Cell Proteomics. 11, (2012).
  21. Gramolini, A. O., et al. Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses. Mol Cell Proteomics. 7, 519-533 (2008).
  22. Singh, H., Warburton, S., Vondriska, T. M., Khakh, B. S. Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels. J. Vis. Exp. (27), e1178 (2009).
  23. Park, S. K., Venable, J. D., Xu, T., Yates, J. R. A quantitative analysis software tool for mass spectrometry-based proteomics. Nat. Methods. 5, 319-322 (2008).
  24. Lomenick, B., et al. Target identification using drug affinity responsive target stability (DARTS). Proc. Natl. Acad. Sci. U. S. A. 106, 21984-21989 (2009).
  25. Kamleh, A., et al. Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: a method with wide applicability to analysis of biomolecules. Rapid Commun. Mass Spectrom. 22, 1912-1918 (2008).
  26. Searle, B. C. Scaffold: a bioinformatic tool for validating MS/MS-based proteomic studies. Proteomics. 10, 1265-1269 (2010).
  27. Murray, K. The Basic Proteins of Cell Nuclei. Annu Rev. Biochem. 34, 209-246 (1965).
  28. Johns, E. W., Phillips, D. M., Simson, P., Butler, J. A. Improved fractionations of arginine-rich histones from calf thymus. Biochem. J. 77, 631-636 (1960).
  29. Rodriguez-Collazo, P., Leuba, S. H., Zlatanova, J. Robust methods for purification of histones from cultured mammalian cells with the preservation of their native modifications. Nucleic Acids Res. 37, e81 (2009).
  30. Kuehl, L., Salmond, B., Tran, L. Concentrations of high-mobility-group proteins in the nucleus and cytoplasm of several rat tissues. J. Cell Biol. 99, 648-654 (1984).
  31. Gronow, M., Griffiths, G. Rapid isolation and separation of the non-histone proteins of rat liver nuclei. FEBS Lett. 15, 340-344 (1971).
  32. Mischke, B. G., Ward, O. G. Isolation and tissue specificity of chromatin-associated proteins in Vicia faba. Can J. Biochem. 53, 91-95 (1975).
  33. Andersen, J. S., et al. Directed proteomic analysis of the human nucleolus. Curr. Biol. 12, 1-11 (2002).
  34. Zhao, Y., Jensen, O. N. Modification-specific proteomics: strategies for characterization of post-translational modifications using enrichment techniques. Proteomics. 9, 4632-4641 (2009).
  35. Ahrne, E., Muller, M., Lisacek, F. Unrestricted identification of modified proteins using MS/MS. Proteomics. 10, 671-686 (2010).
  36. Young, N. L., Plazas-Mayorca, M. D., Garcia, B. A. Systems-wide proteomic characterization of combinatorial post-translational modification patterns. Expert Rev. Proteomics. 7, 79-92 (2010).
  37. Guthals, A., Bandeira, N. Peptide identification by tandem mass spectrometry with alternate fragmentation modes. Mol. Cell Proteomics. , (2012).
  38. Wu, C., et al. A protease for ‘middle-down’ proteomics. Nat. Methods. , (2012).
  39. Tran, J. C., et al. Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature. 480, 254-258 (2011).
check_url/it/4294?article_type=t

Play Video

Citazione di questo articolo
Monte, E., Chen, H., Kolmakova, M., Parvatiyar, M., Vondriska, T. M., Franklin, S. Quantitative Analysis of Chromatin Proteomes in Disease. J. Vis. Exp. (70), e4294, doi:10.3791/4294 (2012).

View Video